financetom
Business
financetom
/
Business
/
Ionis Pharmaceuticals' Q3 Loss Narrows, Revenue Decreases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ionis Pharmaceuticals' Q3 Loss Narrows, Revenue Decreases
Nov 6, 2024 5:39 AM

08:08 AM EST, 11/06/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q3 loss Wednesday of $0.95 per diluted share, narrower than the $1.03 loss a year earlier.

Analysts polled by Capital IQ expected a loss of $1.16.

Revenue for the quarter ended Sept. 30 was $134 million, compared with $144 million a year earlier.

Analysts surveyed by Capital IQ expected $134 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cineplex Says 'Wicked: For Good' Pre-Sales Hit $4.7 Million Ahead of
Cineplex Says 'Wicked: For Good' Pre-Sales Hit $4.7 Million Ahead of "Magical" Opening Weekend
Nov 21, 2025
07:35 AM EST, 11/21/2025 (MT Newswires) -- Cineplex ( CPXGF ) , a Canadian entertainment and media company, announced on Friday that 'Wicked: For Good' is set to deliver a magical opening weekend at the box office, achieving $4.7 million in pre-sales alone, a 52% increase over 'Wicked' pre-sales in 2024. The Wicked: For Good pre-sale is a testament to...
Elastic's Fiscal Q2 Sales-Led Growth Below Target a 'Speed Bump,' Wedbush Says
Elastic's Fiscal Q2 Sales-Led Growth Below Target a 'Speed Bump,' Wedbush Says
Nov 21, 2025
07:41 AM EST, 11/21/2025 (MT Newswires) -- Elastic (ESTC) fiscal Q2 sales-led subscription revenue growth came in below targets set during October's analyst day, but Wedbush said in a a note on Friday that it was merely a 'speed bump'. The brokerage firm said Elastic's fiscal Q2 beat both bottom and top line Wall Street expectations, and the company raised...
GFL Holders to Sell 16.6-Million Shares at US$45.15 Each; Company to Buy Back 1.28-Million
GFL Holders to Sell 16.6-Million Shares at US$45.15 Each; Company to Buy Back 1.28-Million
Nov 21, 2025
07:30 AM EST, 11/21/2025 (MT Newswires) -- GFL Environmental ( GFL ) said Friday that certain shareholders plan to sell 16,611,295 subordinate voting shares in the company at US$45.15 per share The shareholders are BCEC-GFL Borrower (Cayman) LP, an entity affiliated with BC Partners Advisors; Ontario Teachers' Pension Plan Board; GFL Borrower II (Cayman) LP and entities affiliated with HPS...
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
Nov 21, 2025
EMERYVILLE, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation ( XOMA ) today announced it has successfully completed its previously announced acquisition of all the outstanding common shares of LAVA Therapeutics N.V. ( LVTX ) (“LAVA”) with a nominal value of €0.12 per share (“Shares”).  LAVA shareholders received $1.04 in cash per Share and a non-transferrable contingent value...
Copyright 2023-2026 - www.financetom.com All Rights Reserved